Aleong R., Aumont N., Blain J. F., Poirier J. (2007). Pro-inflammatory cytokines mediate in vitro glial expression of apolipoprotein E protein-implications for the treatment of Alzheimer’s disease, Curr Alz Dis, 5, 33-37.

Fiocco A. J., Joober R., Poirier J., Lupien S. J. (2007). Polymorphism of the 5HT2A Receptor Gene: Association with Stress-Related Indices in Healthy Baby Boomers, Frontier Behavior. Neurosci, 1(3), 1-7.

Gauthier S., Poirier J. (2007). Survol des facteurs génétiques et de quelques enjeux éthiquers liés à la maladie d’Alzheimer, L’Observatoire de la génétique, www.ircm.qc.ca/bioéthique/obsgenetique, Fev/Mars.

Gauthier S., Poirier J. (2007). Maladie d’Alzheimer . In Arcand M. & Hébert R. (Eds.) , Précis de Gériatrie (pp. 257-266). Edisem Inc..

Petit-Turcotte C., Aumont N., Blain J. F., Poirier J. (2007). Apolipoprotein E receptors and amyloid expression are modulated in an apolipoprotein E-dependent fashion in response to hippocampal deafferentation in rodent, Neuroscience, 150(1), 58-63.

Poirier J. (2007). Apolipoprotein E: a potent gene-based therapeutic target for the treatment sporadic Alzheimer’s disease . In Cuello C. (Ed.) , Pharmacological and Mechanisms in Alzheimer's Therapeutic (pp. 212-222). Springer.

Poirier J. (2007). Cholesterol Transport and Production In Alzheimer's Disease . In Fisher. A. & Hanin I. (Eds.) , Advances In Behavioral Biology (pp. 101-106). Plenum Publishers.